tiprankstipranks
Trending News
More News >
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market

ENDRA Life Sciences (NDRA) Financial Statements

Compare
853 Followers

ENDRA Life Sciences Financial Overview

ENDRA Life Sciences's market cap is currently $5.35M. The company's EPS TTM is $-2.1; its P/E ratio is -0.33; ENDRA Life Sciences is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $-1.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -275.45K$ -234.26K$ -224.41K$ -165.25K
Operating Income$ -10.82M$ -10.52M$ -13.16M$ -11.50M$ -11.50M
EBITDA$ -10.77M$ -9.78M$ -12.94M$ -11.01M$ -11.33M
Net Income$ -11.51M$ -10.06M$ -13.18M$ -11.23M$ -11.73M
Balance Sheet
Cash & Short-Term Investments$ 3.23M$ 2.83M$ 4.89M$ 9.46M$ 7.23M
Total Assets$ 4.45M$ 6.75M$ 9.27M$ 12.87M$ 8.76M
Total Debt$ 584.42K$ 394.40K$ 546.63K$ 796.09K$ 769.34K
Net Debt$ -2.65M$ -2.44M$ -4.34M$ -8.67M$ -6.46M
Total Liabilities$ 1.89M$ 1.10M$ 2.07M$ 2.09M$ 1.60M
Stockholders' Equity$ 2.56M$ 5.66M$ 7.20M$ 10.78M$ 7.17M
Cash Flow
Free Cash Flow$ -7.42M$ -9.58M$ -12.97M$ -11.17M$ -10.82M
Operating Cash Flow$ -7.40M$ -9.55M$ -12.77M$ -11.12M$ -10.77M
Investing Cash Flow$ -12.80K$ -24.72K$ -202.58K$ -45.00K$ -51.33K
Financing Cash Flow$ 7.81M$ 7.52M$ 8.40M$ 13.40M$ 11.88M
Currency in USD

ENDRA Life Sciences Earnings and Revenue History

ENDRA Life Sciences Debt to Assets

ENDRA Life Sciences Cash Flow

ENDRA Life Sciences Forecast EPS vs Actual EPS